dddmag.com
Drug Discovery & Development  
  NEWSLETTERS      |      WHITE PAPERS      |      SUBSCRIBE      |      ADVERTISE      |      CONTACT US      |      ABOUT US    

  Today is: 

News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News






SITE SPONSORS 
Advertise with Us
 

Browse Drug Development News:


GSK Withdrawing Cancer Drug Application
British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer.  continue



 Immunovaccine Licenses Technology to Pfizer
Immunovaccine Inc. said that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.  continue



 Raptor Drug Meets Key Goals
Raptor Pharmaceutical Corp. said its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.  continue



 Advisory Panel Recommends Merck Fertility Drug
Drug developer Merck & Co. said a European advisory committee recommended approval for the company's fertility drug Elonva.  continue



 FDA Panel Backs Spiriva Handihaler
Federal health experts brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims.  continue
Matthew Perrone


Experimental Drug Might Restore Spinal Cord Function
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.  continue



 Pharmasset to Continue Hepatitis C Trial
Pharmasset Inc. will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.  continue
Matthew Perrone


Bevacizumab Effective Against Biliary-Tract Cancers
Bevacizumab given in addition to the combined chemotherapy regimen of gemcitabine and oxaliplatin (GEMOX-B) is well tolerated and shows promising antitumour activity in patients with advanced biliary-tract cancers.  continue



 Abbott Initiates Trial For Bioabsorbable Stent
Abbott announced three-year data demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries  continue



 Activity Test Improves Prediction of Cardiovascular Events
Aterovax SA, announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease over a five-year period.  continue



Most Popular


  1. GSK To Eliminate 4,000 Jobs

  2. AstraZeneca To Layoff 8,000 Workers

  3. Pfizer Pares, Refocuses Research After Wyeth Buy

  4. Understanding Fragile X Syndrome

  5. Ataluren for Nonsense Mutation Genetic Disorders

  6. Validating Neurogenesis as a Therapeutic Target for Depression

  7. Exenatide Once-Weekly Superior to Twice-Daily Injection

  8. Victoza Gains FDA Approval

  9. HIV Researchers Reveal Integrase Structure

  10. Thermo Fisher Scientific Acquires Finnzymes